Literature DB >> 1644895

Immunoregulatory mechanisms of the eye.

J W Streilein1, G A Wilbanks, S W Cousins.   

Abstract

Immune-privileged sites, such as the the internal compartments of the eye, and perhaps the brain, are physiological adaptations that act to modify systemic immune responses such that effector mechanisms that invoke locally destructive inflammation are suppressed. In the case of the eye, the parenchymal cells of the iris and ciliary body create an intraocular microenvironment that alters both the induction and expression of immunity to antigens placed within the eye. The immunosuppressive properties of the intraocular microenvironment are mediated by cytokines, especially transforming growth factor-beta (TGF beta). This cytokine has been demonstrated to endow intraocular antigen-presenting cells with the capacity to induce an atypical or deviant form of immunity to intraocular antigens which is selectively deficient in T cells that mediate delayed hypersensitivity. Moreover, TGF beta, along with other intraocular factors, can impair the intraocular expression of pre-existing cell-mediated immunity by inhibiting antigen-driven activation of primed T cells. The strategies employed by the eye to engender specialized immune responses appropriate to its physiological functions are discussed in terms of other privileged sites such as the brain.

Entities:  

Mesh:

Year:  1992        PMID: 1644895     DOI: 10.1016/0165-5728(92)90253-h

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  25 in total

1.  Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man.

Authors:  M Muhaya; V L Calder; H M Towler; G Jolly; M McLauchlan; S Lightman
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 2.  Anterior uveitis: clinical and research perspectives.

Authors:  J T Rosenbaum; T M Martin; S R Planck
Journal:  Springer Semin Immunopathol       Date:  1999

3.  Analysis of cytokine dynamics in corneal allograft rejection.

Authors:  C C Chan; J Stark; A J George
Journal:  Proc Biol Sci       Date:  1999-11-07       Impact factor: 5.349

Review 4.  Experimental corneal allograft rejection.

Authors:  Bryan M Gebhardt; Weiyun Shi
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 5.  Immunology of corneal transplantation.

Authors:  W H Constad; K Taraschanskiy
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 6.  Novel mechanisms of class II major histocompatibility complex gene regulation.

Authors:  Michael Radosevich; Santa Jeremy Ono
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  HLA class II genotypes are not associated with age related macular degeneration in a case-control, population-based study.

Authors:  Derek Pappas; Jill Hollenbach; Anne L Coleman; Michael B Gorin; Fe Yu; Kevin Williams; Janelle Noble; Gregory J Tranah
Journal:  Hum Immunol       Date:  2015-02-07       Impact factor: 2.850

Review 8.  The changing immunology of organ transplantation.

Authors:  T E Starzl; A J Demetris; N Murase; M Trucco; A W Thomson; A S Rao
Journal:  Hosp Pract (1995)       Date:  1995-10-15

9.  Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.

Authors:  Takeshi Kita; Yasuaki Hata; Ryoichi Arita; Shuhei Kawahara; Muneki Miura; Shintaro Nakao; Yasutaka Mochizuki; Hiroshi Enaida; Yoshinobu Goto; Hiroaki Shimokawa; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

10.  Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen.

Authors:  L Lu; J Woo; A S Rao; Y Li; S C Watkins; S Qian; T E Starzl; A J Demetris; A W Thomson
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.